Design of probes specific for PSMA or NAALADaseL1 to identify early stage neuroendocrine-like prostate cancer

Design of probes specific for PSMA or NAALADaseL1 to identify early stage neuroendocrine-like prostate cancer


Dr. John Trant

University of Windsor

 

The project aims to provide a pair of probes to distinguish between PSMA-positive prostate cancer and NAALADaseL1 positive prostate cancer (associated with neuroendocrine and likely treatment resistant). It can also help determine if a cancer is progressing from one stage to another.

Related Programs:
Nucleus Cores:

FUNDER:

WE-SPARK Health Institute

GRANT DURATION:

2021-2022

CO-APPLICANTS

University of Windsor

  • Dr. Lisa Porter

 

 

Loading...